Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

@article{Tanoue2012AnaplasticLK,
  title={Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer},
  author={Lynn T Tanoue},
  journal={Yearbook of Pulmonary Disease},
  year={2012},
  volume={2012},
  pages={99-101}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 2,029 CITATIONS

Ceritinib: A primer for pharmacists.

  • Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
  • 2017
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Targeting ALK: Precision Medicine Takes on Drug Resistance.

VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Drug-diagnostic co-development: challenges and issues.

  • Expert review of molecular diagnostics
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Specialty pharmacy services for patients receiving oral medications for solid tumors.

  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2016
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?

  • Expert review of anticancer therapy
  • 2015
VIEW 14 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Crizotinib-Induced Abnormal Signal Processing in the Retina

VIEW 13 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 183 Highly Influenced Citations

  • Averaged 191 Citations per year over the last 3 years

Similar Papers

Loading similar papers…